Research Priorities
HICOR strives to reduce the human and economic burden of cancer by conducting innovative research in the following areas:
- Financial impact of cancer
- Cancer outcomes
- Cost-effectiveness research
- Pragmatic clinical trials
- Economic assessment of technologies and treatments
- Cancer policy
- Value of information
- Cancer care delivery research
HICOR co-director Dr. Gary Lyman explains how HICOR partners with care providers, insurance companies, patient advocates, drug companies and other researchers to untangle the financial burden cancer patients face through treatment.
